Daniel Sumarriva, Executive Medical Director at SAGA Diagnostics, shared on LinkedIn:
“Kicking off an inspiring first day at ISLB25 in Orlando!
Excited to hear from thought leaders in Liquid Biopsy, MRD and Precision Medicine and work with the International Society of Liquid Biopsy to shape the future of cancer diagnostics and clinical triage.
Proud to represent SAGA Diagnostics and our work with Pathlight MRD – pushing the boundaries of ultra-sensitive, personalized cancer monitoring.”
More posts from ISLB25 on OncoDaily.